TAmiRNA launched thrombomiR™ - a simple and standardized test for analysis of platelet function using circulating microRNAs.

Early this year, TAmiRNA launched the new thrombomiR™ test. It enables researchers and clinicians to quantify platelet derived microRNAs in only a droplet of human plasma, in order to monitor anti-platelet therapy and estimate bleeding risk.

Sorry, this entry is only available in German!

The sender takes full responsibility for the content of this news item. Content may include forward-looking statements which, at the time they were made, were based on expectations of future events. Readers are cautioned not to rely on these forward-looking statements.

As a life sciences organization based in Vienna, would you like us to promote your news and events? If so, please send your contributions to news(at)lisavienna.at.